Camila V. Blair and Colleagues on The Association of CAD by Coronary CT Angiography and Cardiovascular Outcomes in Psoriatic Disease
Camila V. Blair, Postdoctoral Research Fellow at Brigham and Women’s Hospital, reposted from American Journal of Preventive Cardiology on LinkedIn:
”Our manuscript is out!
Thrilled to share our latest publication in the American Journal of Preventive Cardiology
Among patients with psoriatic disease (PsO) referred for coronary CT angiography (CCTA):
- Both non-obstructive and obstructive coronary artery disease (CAD) were highly prevalent and associated with a stepwise increase in major adverse cardiovascular events (MACE).
- Risk of MACE rose with increasing plaque burden, and obstructive CAD remained significantly associated with MACE after traditional CV risk factors adjustment.
- Participants with coronary plaque often had low estimated 10-year ASCVD risk scores, below thresholds for statin initiation, revealing a gap between traditional risk prediction and true atherosclerotic burden in individuals with psoriasis.
Our findings reinforce the need for interdisciplinary strategies for prevention, bridging dermatology, rheumatology, and cardiology, to better identify and manage cardiovascular risk in immune-mediated inflammatory diseases.
Grateful to collaborate with this incredible team led by Jonathan Aun, Ron Blankstein, Brittany Weber.”
Quoting American Journal of Preventive Cardiology‘s post:
”New study: Coronary CT angiography reveals that coronary artery disease is strongly linked to adverse cardiovascular outcomes in patients with psoriatic disease.”
Read the full article here.
Article: The Association of Coronary Artery Disease by Coronary CT Angiography and Cardiovascular Outcomes in Psoriatic Disease
Authors: Jonathan A. Aun, Daniel M. Huck, Stephanie A. Besser, Arthur Shiyovich, Milena Petranovic, Adam N. Berman, Camila Veronica Blair, Christos P. Kotanidis, Jon Hainer, Dave W. Biery, Nayruti Trivedi, Khaled Abdelrahman, Rhanderson Cardoso, Joseph Merola, Michael Garshick, Brian Ghoshhajra, Sandeep Hegdire, Marcelo Di Carli, Ron Blankstein, Brittany N. Weber

Stay updated on all scientific advances with Hemostasis Today.
-
Jul 12, 2026, 12:30Reduced-Dose DOACs in GI Malignancies: Toward Personalized Anticoagulation
-
Jul 12, 2026, 08:50Where the Hemophilia Community Comes Together at ISTH 2026 – EAHAD
-
Jul 12, 2026, 08:2210 Posts Not To Miss from ISTH 2026, Part 1
-
Jul 12, 2026, 07:58Brian O Mahony: Could NXT-007 Minimize the Need for Perioperative FVIII
-
Jul 12, 2026, 07:50Shayan Mohammadmoradi: Connecting the Next Generation of Hemostasis Researchers at ISTH 2026
-
Jul 12, 2026, 07:42Alexandra Yakusheva: ThrombInnov Debuts at ISTH 2026 with a Focus on Translational Research
-
Jul 12, 2026, 07:34Wolfgang Miesbach: ISTH 2026 Explores the Next Generation of APS Diagnostics
-
Jul 12, 2026, 07:28Sara Zalghout: ISTH 2026 Highlights Progress in Thromboinflammation Research
-
Jul 12, 2026, 07:13Ekaterina Balaian: Finding Healing Through Art at ISTH 2026